For comparison, 3 additional samples from our CCA sequencing cohort without APC/CTNNB1 mutation were randomly selected (P5–7), and membranous β-catenin staining was verified by immunohistochemistry (Figure S3b). This evidence concerns the gene CTNNB1 and cholangiocarcinoma.